Genfit SA

GENFIT Reports First Quarter 2025 Financial Information

22 May 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy

20 May 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024)

14 May 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents

07 May 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT to Present Latest ACLF Research at EASL Congress 2025

04 May 2025 22:30:00 By Nasdaq GlobeNewswire

GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F

29 Apr 2025 12:10:00 By Nasdaq GlobeNewswire

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

28 Apr 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update

24 Apr 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders

20 Mar 2025 14:10:00 By Nasdaq GlobeNewswire

Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs

10 Mar 2025 14:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Revenues and Cash Position as of December 31, 2024

27 Feb 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders’ general meeting

20 Feb 2025 23:30:00 By Nasdaq GlobeNewswire

GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders

14 Feb 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders

09 Feb 2025 22:30:00 By Nasdaq GlobeNewswire

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025

06 Feb 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan

29 Jan 2025 23:40:00 By Nasdaq GlobeNewswire

GENFIT Announces 2025 Financial Calendar

29 Jan 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

13 Jan 2025 13:10:00 By Nasdaq GlobeNewswire

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

13 Nov 2024 13:10:00 By Nasdaq GlobeNewswire

GENFIT Reports Third Quarter 2024 Financial Information

07 Nov 2024 13:10:00 By Nasdaq GlobeNewswire